QuickView for Thy-1;jsessionid=011CF923678866240A0AFA39DB3FF7BC;jsessionid=469EB5DB5BA323E16AE04AF9D11394C5;jsessionid=8E43C2EF0A07BE06C199C1A34AF33D77;jsessionid=46FCFE6415A6D864E20A509C6F02682C;jsessionid=C7235058F56A98F329E54BCCE65A39FE;jsessionid=3E9C371993C751A11E61C5CAC51387BB;jsessionid=570A1C4C2D78718F78709643BA555929 (gene)

1. Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblas…
2. Donor CD7 Chimeric Antigen Receptor T Cell Bridging to Allogeneic Hematopoietic Stem Cell Transplant…
3. Expression of CD7 and its correlation with prognosis in patients with NK/T-cell lymphoma].
4. Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed a…
5. An antibody-drug conjugate with intracellular drug release properties showing specific cytotoxicity …

There were no clinical trials for Thy-1;jsessionid=011CF923678866240A0AFA39DB3FF7BC;jsessionid=469EB5DB5BA323E16AE04AF9D11394C5;jsessionid=8E43C2EF0A07BE06C199C1A34AF33D77;jsessionid=46FCFE6415A6D864E20A509C6F02682C;jsessionid=C7235058F56A98F329E54BCCE65A39FE;jsessionid=3E9C371993C751A11E61C5CAC51387BB;jsessionid=570A1C4C2D78718F78709643BA555929